Risk of severe disease and mortality of COVID-19 in patients with Budd-Chiari syndrome: A population-based matched cohort study.

Arunkumar KrishnanCarolin V SchneiderJörn Markus Schattenberg Saleh A Alqahthani

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

In conclusion, COVID-19 infection in patients with BCS is associated with poor outcomes. Patients with BCS infected with COVID-19 carry a significantly higher risk of hospitalization and all-cause mortality and a possible effect on severe disease and AKI compared with COVID-19 patients without CLD or with non-BCS-CLD.

Keyphrases

sars cov
coronavirus disease
early onset
acute kidney injury
inferior vena cava
risk factors
drug induced
adipose tissue
pulmonary embolism